EGFR Tyrosine Kinase Inhibitor Sequencing Revisited: From the Revival of Old Tools to the Integration of New Agents. Girard N. J Thorac Oncol 2022;17:1067-1069.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Girard N. EGFR Tyrosine Kinase Inhibitor Sequencing Revisited: From the Revival of Old Tools to the Integration of New Agents. J Thorac Oncol 2022;17:1067-1069.
PMID: 36031285